レタパムリンの世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE3994)
◆英語タイトル:Global Retapamulin Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE3994
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月
◆ページ数:86
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥546,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥819,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,092,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、レタパムリンの世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(1%軟膏(15グラムチューブ)、1%軟膏(30グラムチューブ))、用途別市場規模(病院、ドラッグストア)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・レタパムリンの市場動向
・企業の競争状況、市場シェア
・レタパムリンの種類別市場規模(1%軟膏(15グラムチューブ)、1%軟膏(30グラムチューブ))
・レタパムリンの用途別市場規模(病院、ドラッグストア)
・レタパムリンの北米市場規模2016-2027(アメリカ、カナダ)
・レタパムリンの欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・レタパムリンのアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・レタパムリンの中南米市場規模2016-2027(メキシコ、ブラジル)
・レタパムリンの中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Almirall)
・結論
【レポートの概要】

Retapamulin is a topical antibiotic developed by GlaxoSmithKline. It is the first drug in the new class of pleuromutilin antibiotics to be approved for human use. It is marketed as an ointment under the brand names Altabax and Altargo.

Market Analysis and Insights: Global Retapamulin Market
The global Retapamulin market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Retapamulin market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Retapamulin market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Retapamulin market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Retapamulin market.

Global Retapamulin Scope and Market Size
Retapamulin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Retapamulin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
1% ointment(15-gram tubes)
1% ointment(30-gram tubes)

Segment by Application
Hospital
Drug store

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Almirall

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Retapamulin Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 1% ointment(15-gram tubes)
1.2.3 1% ointment(30-gram tubes)
1.3 Market by Application
1.3.1 Global Retapamulin Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Drug store
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Retapamulin Market Perspective (2016-2027)
2.2 Retapamulin Growth Trends by Regions
2.2.1 Retapamulin Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Retapamulin Historic Market Share by Regions (2016-2021)
2.2.3 Retapamulin Forecasted Market Size by Regions (2022-2027)
2.3 Retapamulin Industry Dynamic
2.3.1 Retapamulin Market Trends
2.3.2 Retapamulin Market Drivers
2.3.3 Retapamulin Market Challenges
2.3.4 Retapamulin Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Retapamulin Players by Revenue
3.1.1 Global Top Retapamulin Players by Revenue (2016-2021)
3.1.2 Global Retapamulin Revenue Market Share by Players (2016-2021)
3.2 Global Retapamulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Retapamulin Revenue
3.4 Global Retapamulin Market Concentration Ratio
3.4.1 Global Retapamulin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Retapamulin Revenue in 2020
3.5 Retapamulin Key Players Head office and Area Served
3.6 Key Players Retapamulin Product Solution and Service
3.7 Date of Enter into Retapamulin Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Retapamulin Breakdown Data by Type
4.1 Global Retapamulin Historic Market Size by Type (2016-2021)
4.2 Global Retapamulin Forecasted Market Size by Type (2022-2027)

5 Retapamulin Breakdown Data by Application
5.1 Global Retapamulin Historic Market Size by Application (2016-2021)
5.2 Global Retapamulin Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Retapamulin Market Size (2016-2027)
6.2 North America Retapamulin Market Size by Type
6.2.1 North America Retapamulin Market Size by Type (2016-2021)
6.2.2 North America Retapamulin Market Size by Type (2022-2027)
6.2.3 North America Retapamulin Market Size by Type (2016-2027)
6.3 North America Retapamulin Market Size by Application
6.3.1 North America Retapamulin Market Size by Application (2016-2021)
6.3.2 North America Retapamulin Market Size by Application (2022-2027)
6.3.3 North America Retapamulin Market Size by Application (2016-2027)
6.4 North America Retapamulin Market Size by Country
6.4.1 North America Retapamulin Market Size by Country (2016-2021)
6.4.2 North America Retapamulin Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Retapamulin Market Size (2016-2027)
7.2 Europe Retapamulin Market Size by Type
7.2.1 Europe Retapamulin Market Size by Type (2016-2021)
7.2.2 Europe Retapamulin Market Size by Type (2022-2027)
7.2.3 Europe Retapamulin Market Size by Type (2016-2027)
7.3 Europe Retapamulin Market Size by Application
7.3.1 Europe Retapamulin Market Size by Application (2016-2021)
7.3.2 Europe Retapamulin Market Size by Application (2022-2027)
7.3.3 Europe Retapamulin Market Size by Application (2016-2027)
7.4 Europe Retapamulin Market Size by Country
7.4.1 Europe Retapamulin Market Size by Country (2016-2021)
7.4.2 Europe Retapamulin Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Retapamulin Market Size (2016-2027)
8.2 Asia-Pacific Retapamulin Market Size by Type
8.2.1 Asia-Pacific Retapamulin Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Retapamulin Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Retapamulin Market Size by Type (2016-2027)
8.3 Asia-Pacific Retapamulin Market Size by Application
8.3.1 Asia-Pacific Retapamulin Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Retapamulin Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Retapamulin Market Size by Application (2016-2027)
8.4 Asia-Pacific Retapamulin Market Size by Region
8.4.1 Asia-Pacific Retapamulin Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Retapamulin Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Retapamulin Market Size (2016-2027)
9.2 Latin America Retapamulin Market Size by Type
9.2.1 Latin America Retapamulin Market Size by Type (2016-2021)
9.2.2 Latin America Retapamulin Market Size by Type (2022-2027)
9.2.3 Latin America Retapamulin Market Size by Type (2016-2027)
9.3 Latin America Retapamulin Market Size by Application
9.3.1 Latin America Retapamulin Market Size by Application (2016-2021)
9.3.2 Latin America Retapamulin Market Size by Application (2022-2027)
9.3.3 Latin America Retapamulin Market Size by Application (2016-2027)
9.4 Latin America Retapamulin Market Size by Country
9.4.1 Latin America Retapamulin Market Size by Country (2016-2021)
9.4.2 Latin America Retapamulin Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Retapamulin Market Size (2016-2027)
10.2 Middle East & Africa Retapamulin Market Size by Type
10.2.1 Middle East & Africa Retapamulin Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Retapamulin Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Retapamulin Market Size by Type (2016-2027)
10.3 Middle East & Africa Retapamulin Market Size by Application
10.3.1 Middle East & Africa Retapamulin Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Retapamulin Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Retapamulin Market Size by Application (2016-2027)
10.4 Middle East & Africa Retapamulin Market Size by Country
10.4.1 Middle East & Africa Retapamulin Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Retapamulin Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Almirall
11.1.1 Almirall Company Details
11.1.2 Almirall Business Overview
11.1.3 Almirall Retapamulin Introduction
11.1.4 Almirall Revenue in Retapamulin Business (2016-2021)
11.1.5 Almirall Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ レタパムリンの世界市場規模・現状・予測2021年-2027年(Global Retapamulin Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。